Literature DB >> 18093131

Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease?

W T Cade1, D N Reeds, S Lassa-Claxton, V G Davila-Roman, A D Waggoner, W G Powderly, K E Yarasheski.   

Abstract

BACKGROUND: HIV infection and its treatment, specifically protease inhibitor (PI) therapy, have been associated with an increased risk for cardiovascular disease. Heart rate recovery (HRR) following peak exercise is predictive of future cardiovascular events and mortality in the general population. Nothing is known regarding HRR in individuals infected with HIV on highly active antiretroviral therapy (HAART). SUBJECTS AND METHODS: HIV-positive subjects on HAART that included a PI (HIV+PI, n=19), HIV-positive subjects on HAART that did not include a PI (HIV+noPI, n=19) and HIV-seronegative age, gender and body mass index (BMI) matched controls (Cntl, n=15) underwent a graded maximal exercise test on a cycle ergometer to volitional exhaustion. A continuous electrocardiogram was recorded and HRR was monitored every 30 s for 2 min post exercise.
RESULTS: HRR at 1.5 and 2 min was significantly delayed in HIV-positive subjects both on and not on PI-based HAART compared with controls (P<0.01).
CONCLUSION: HRR is impaired in HIV-positive individuals on HAART, whether or not the HAART includes a PI, compared with age, gender, BMI, and activity level matched HIV-seronegative controls. Abnormal HRR may reflect cardio-autonomic dysfunction and may be an independent risk factor for future cardiac events in HIV-positive individuals that receive HAART.

Entities:  

Mesh:

Year:  2007        PMID: 18093131      PMCID: PMC4297631          DOI: 10.1111/j.1468-1293.2007.00524.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  23 in total

1.  Association of smoking with abnormal exercise heart rate responses and long-term prognosis in a healthy, population-based cohort.

Authors:  R Srivastava; E H Blackstone; M S Lauer
Journal:  Am J Med       Date:  2000-07       Impact factor: 4.965

2.  HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells.

Authors:  Dian-sheng Zhong; Xiang-huai Lu; Brian S Conklin; Peter H Lin; Alan B Lumsden; Qizhi Yao; Changyi Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

3.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

4.  Heart-rate profile during exercise as a predictor of sudden death.

Authors:  Xavier Jouven; Jean-Philippe Empana; Peter J Schwartz; Michel Desnos; Dominique Courbon; Pierre Ducimetière
Journal:  N Engl J Med       Date:  2005-05-12       Impact factor: 91.245

5.  Insulin resistance in HIV protease inhibitor-associated diabetes.

Authors:  K E Yarasheski; P Tebas; C Sigmund; S Dagogo-Jack; A Bohrer; J Turk; P A Halban; P E Cryer; W G Powderly
Journal:  J Acquir Immune Defic Syndr       Date:  1999-07-01       Impact factor: 3.731

6.  Effects of HIV protease inhibitor ritonavir on vasomotor function and endothelial nitric oxide synthase expression.

Authors:  Weiping Fu; Hong Chai; Qizhi Yao; Changyi Chen
Journal:  J Acquir Immune Defic Syndr       Date:  2005-06-01       Impact factor: 3.731

7.  Heart rate recovery following maximal exercise testing as a predictor of cardiovascular disease and all-cause mortality in men with diabetes.

Authors:  Yiling J Cheng; Michael S Lauer; Conrad P Earnest; Timothy S Church; James B Kampert; Larry W Gibbons; Steven N Blair
Journal:  Diabetes Care       Date:  2003-07       Impact factor: 19.112

8.  A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Authors:  A Carr; K Samaras; S Burton; M Law; J Freund; D J Chisholm; D A Cooper
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

9.  Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study.

Authors:  M S Lauer; P M Okin; M G Larson; J C Evans; D Levy
Journal:  Circulation       Date:  1996-04-15       Impact factor: 29.690

10.  High frequency of human immunodeficiency virus-associated autonomic neuropathy and more severe involvement in advanced stages of human immunodeficiency virus disease.

Authors:  S Rüttimann; P Hilti; G A Spinas; U C Dubach
Journal:  Arch Intern Med       Date:  1991-12
View more
  9 in total

1.  HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters.

Authors:  Scott R Richmond; Michael J Carper; Xiaoyong Lei; Sheng Zhang; Kevin E Yarasheski; Sasanka Ramanadham
Journal:  Biochim Biophys Acta       Date:  2010-02-01

2.  Atypical autonomic regulation, auditory processing, and affect recognition in women with HIV.

Authors:  K J Heilman; E R Harden; K M Weber; M Cohen; S W Porges
Journal:  Biol Psychol       Date:  2013-06-17       Impact factor: 3.251

3.  Aerobic fitness levels and validation of a non exercise VO2max prediction equation for HIV-infected patients on HAART.

Authors:  Katherine Sullivan; Cecilia M Shikuma; Dominic Chow; Elizabeth Cornelius; Rebecca K Romine; Rachel A Lindsey; Christopher D Stickley; Iris F Kimura; Ronald K Hetzler
Journal:  HIV Clin Trials       Date:  2014 Mar-Apr

4.  Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity.

Authors:  Kevin E Yarasheski; W Todd Cade; E Turner Overton; Kristin E Mondy; Sara Hubert; Erin Laciny; Coco Bopp; Sherry Lassa-Claxton; Dominic N Reeds
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-19       Impact factor: 4.310

5.  Physical Activity Affects Brain Integrity in HIV+ Individuals.

Authors:  Mario Ortega; Laurie M Baker; Florin Vaida; Robert Paul; Brian Basco; Beau M Ances
Journal:  J Int Neuropsychol Soc       Date:  2015-11       Impact factor: 2.892

6.  Decreased heart rate variability in HIV positive patients receiving antiretroviral therapy: importance of blood glucose and cholesterol.

Authors:  Gro Askgaard; Ulrik Sloth Kristoffersen; Jesper Mehlsen; Gitte Kronborg; Andreas Kjaer; Anne-Mette Lebech
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

7.  Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.

Authors:  Sanelisiwe Nzuza; Sindiswa Zondi; Peter M O Owira
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

8.  Clinical usefulness of response profiles to rapidly incremental cardiopulmonary exercise testing.

Authors:  Roberta P Ramos; Maria Clara N Alencar; Erika Treptow; Flávio Arbex; Eloara M V Ferreira; J Alberto Neder
Journal:  Pulm Med       Date:  2013-05-12

9.  Association between muscle strength and the cardiopulmonary status of individuals living with HIV/AIDS.

Authors:  Vagner Raso; Roy J Shephard; Jorge Casseb; Alberto José da Silva Duarte; Paulo Roberto Santos Silva; Júlia Maria D'Andréa Greve
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.